Asset Allocation

As of December 31, 2025.
Type % Net
Cash 5.07%
Stock 86.44%
Bond 5.23%
Convertible 0.00%
Preferred 0.02%
Other 3.24%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 90.49%    % Emerging Markets: 1.12%    % Unidentified Markets: 8.39%

Americas 74.48%
74.24%
Canada 3.02%
United States 71.22%
0.24%
Brazil 0.00%
Colombia 0.01%
Mexico 0.07%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 10.31%
United Kingdom 2.19%
8.12%
Belgium 0.17%
Denmark 0.58%
Finland 0.01%
France 0.88%
Germany 0.85%
Ireland 1.58%
Italy 0.06%
Netherlands 0.26%
Norway 0.01%
Sweden 0.33%
Switzerland 3.40%
0.00%
Turkey 0.00%
0.01%
Saudi Arabia 0.01%
Greater Asia 6.82%
Japan 4.96%
0.36%
Australia 0.31%
0.53%
Hong Kong 0.38%
Singapore 0.07%
South Korea 0.00%
Taiwan 0.07%
0.97%
China -0.01%
India 0.88%
Indonesia 0.09%
Malaysia 0.01%
Unidentified Region 8.39%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
28.53%
Materials
2.90%
Consumer Discretionary
6.87%
Financials
15.38%
Real Estate
3.38%
Sensitive
35.16%
Communication Services
3.74%
Energy
2.07%
Industrials
10.65%
Information Technology
18.71%
Defensive
25.56%
Consumer Staples
8.38%
Health Care
11.25%
Utilities
5.93%
Not Classified
10.75%
Non Classified Equity
0.11%
Not Classified - Non Equity
10.64%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 100.0%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial